N-benzyl-2-bromo-N-ethylacetamide CAS 180513-01-3
| CAS No. | 180513-01-3 |
| Molecular Formula | C11H14BrNO |
| Molecular Weight | 256.14 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
N-benzyl-2-bromo-N-ethylacetamide (C11H14BrNO) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, bromine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
CATO supplies N-benzyl-2-bromo-N-ethylacetamide (CAS 180513-01-3), a certified reference material (molecular formula C11H14BrNO, MW 256.14 g/mol) for analytical method development and quality control.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
As a certified reference material (CRM), N-benzyl-2-bromo-N-ethylacetamide meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C11H14BrNO |
| Molecular Weight | 256.14 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2008 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 1 |
Recommended Standards
- 6-Bromo-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline (CAS 1784885-77-3)
- 3-Bromo-5-(piperidin-1-yl)phenol (CAS 1820640-16-1)
- 8-Bromo-2,2-dimethyl-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine (CAS 1782540-56-0)
- 8-Bromo-N,N-dimethyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-amine (CAS 1820666-71-4)
- 2-Cyclobutyl-4-propylpyrimidine-5-carboxylic acid (CAS 1479305-48-0)
- 1-Methyl-3-(3-methylphenyl)piperazine-2,5-dione (CAS 1214135-40-6)
- 2-[(4-Bromophenyl)imino]-3-methyl-1,3-thiazolidin-4-one (CAS 63500-83-4)
- 1,2-Bis(bromomethyl)benzene 1,2-DIBENZYL BROMIDE 91-13-4 A,A'-DIBROMO-O-XYLENE A,A-DIBROMO-O-XYLENE ALPHA,ALPHA'-DIBROMO-2-XYLENE ALPHA,ALPHA'-DIBROMO-O-XYLENE ALPHA,ALPHA-DIBROMO-O-XYLENE AS00651 ATTERCOP-CHM AT113229 O-XYLIDENE DIBROMIDE O-XYLYLENE BROMIDE O-XYLYLENE DIBROMIDE SPEC-INF-BB S2183 (CAS 91-13-4)
- Crizotinib impurity 21 (CAS CATO-C4X-102521)
- 2-hydroxy-2-(piperidin-3-yl)acetic acid hydrochloride (CAS 72351-54-3)
- 4-(4-Nitrophenyl)-1H-pyrazole (CAS 114474-26-9)
- N-methyl-N-(piperidin-4-ylmethyl)acetamide (CAS 85487-99-6)
- 2-(Benzyloxy)-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-amine (CAS 1681024-13-4)
- Neuropeptide AF (human) (CAS 192387-38-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com